NO884052L - PROCEDURE FOR THE PREPARATION OF THERAPEUTIC PREPARATION. - Google Patents

PROCEDURE FOR THE PREPARATION OF THERAPEUTIC PREPARATION.

Info

Publication number
NO884052L
NO884052L NO88884052A NO884052A NO884052L NO 884052 L NO884052 L NO 884052L NO 88884052 A NO88884052 A NO 88884052A NO 884052 A NO884052 A NO 884052A NO 884052 L NO884052 L NO 884052L
Authority
NO
Norway
Prior art keywords
preparation
procedure
therapeutic
therapeutic preparation
Prior art date
Application number
NO88884052A
Other languages
Norwegian (no)
Other versions
NO179434C (en
NO179434B (en
NO884052D0 (en
Inventor
Lorenz Hahn
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NO884052D0 publication Critical patent/NO884052D0/en
Publication of NO884052L publication Critical patent/NO884052L/en
Publication of NO179434B publication Critical patent/NO179434B/en
Publication of NO179434C publication Critical patent/NO179434C/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO884052A 1987-09-15 1988-09-13 Process for preparing a pharmaceutical composition and using a water-soluble monoester as a solubilizing agent NO179434C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3730909 1987-09-15
DE3802355 1988-01-27

Publications (4)

Publication Number Publication Date
NO884052D0 NO884052D0 (en) 1988-09-13
NO884052L true NO884052L (en) 1989-03-16
NO179434B NO179434B (en) 1996-07-01
NO179434C NO179434C (en) 1996-10-09

Family

ID=25859774

Family Applications (1)

Application Number Title Priority Date Filing Date
NO884052A NO179434C (en) 1987-09-15 1988-09-13 Process for preparing a pharmaceutical composition and using a water-soluble monoester as a solubilizing agent

Country Status (24)

Country Link
JP (1) JP3090666B2 (en)
KR (1) KR0131084B1 (en)
AT (1) AT395819B (en)
AU (1) AU628787B2 (en)
BE (1) BE1001204A5 (en)
CA (1) CA1338775C (en)
CH (1) CH683672A5 (en)
DK (1) DK175132B1 (en)
ES (1) ES2012118A6 (en)
FI (1) FI94837C (en)
FR (1) FR2620336B1 (en)
GB (1) GB2209671B (en)
GR (1) GR1002243B (en)
HU (1) HU205010B (en)
IE (1) IE61195B1 (en)
IL (1) IL87746A (en)
IT (1) IT1224886B (en)
LU (1) LU87335A1 (en)
MY (1) MY103769A (en)
NL (1) NL195094C (en)
NO (1) NO179434C (en)
NZ (1) NZ226163A (en)
PT (1) PT88492B (en)
SE (1) SE503279C2 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
KR0148748B1 (en) 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 Pharmaceutical composition containing cyclosporin
GR1000466B (en) * 1989-01-28 1992-07-30 Sandoz Ag Preparation method of novel pharmaceutical forms of cyclosporine
CH679277A5 (en) * 1989-02-09 1992-01-31 Sandoz Ag
GB8916901D0 (en) 1989-07-24 1989-09-06 Sandoz Ltd Improvements in or relating to organic compounds
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
HK1004520A1 (en) 1992-05-13 1998-11-27 Novartis Ag Ophthalmic compositions containing a cyclosporin
PT589843E (en) 1992-09-25 2002-04-29 Novartis Ag PHARMACEUTICAL COMPOSITIONS CONTAINING CYCLOSPORTS
ATE398448T1 (en) * 1993-09-28 2008-07-15 Scherer Gmbh R P PRODUCTION OF SOFT GELATIN CAPSULES
SK164796A3 (en) 1994-11-03 1997-06-04 Dresden Arzneimittel Novel cyclosporine preparation forms for oral administration of and process for producing them
US5834017A (en) * 1995-08-25 1998-11-10 Sangstat Medical Corporation Oral cyclopsporin formulations
US5827822A (en) * 1996-03-25 1998-10-27 Sangstat Medical Corporation Cyclosporin a formulations as nanoparticles
US5766629A (en) * 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
DE19544507B4 (en) 1995-11-29 2007-11-15 Novartis Ag Cyclosporin containing preparations
TW414696B (en) * 1996-07-01 2000-12-11 Mitsubishi Kagaku Foods Kk Anti-bacteria agent
SK285019B6 (en) 1997-01-30 2006-04-06 Novartis Ag Hard gelatine capsule
GB2326337A (en) * 1997-06-20 1998-12-23 Phares Pharma Holland Homogeneous lipid compositions for drug delivery
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
EP1558215A4 (en) * 2003-10-14 2007-09-12 Wockhardt Ltd Sterile gelling agents
JP5422871B2 (en) * 2006-10-24 2014-02-19 不二製油株式会社 Isoflavones composition

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL284933A (en) * 1961-10-31
GB1134878A (en) * 1966-05-12 1968-11-27 Suga Kazuo Improvements in and relating to oryzanol solutions and compositions
FR5986M (en) * 1966-11-22 1968-06-21
BE787842A (en) * 1971-08-25 1972-12-18 Sumito Chemical Cy Ltd PROCESS FOR PREPARING AN AQUEOUS SUSPENSION OF STABLE CRYSTALS OF THE NON-BETA TYPE OF HIGHER FATTY ACID ESTERS OF CHLORAMPHENICOL
JPS53107408A (en) * 1977-02-28 1978-09-19 Yamanouchi Pharmaceut Co Ltd Micellar preparation for rectal infusion
DE2907460A1 (en) * 1978-03-07 1979-09-13 Sandoz Ag NEW RESORBABLE GALENIC COMPOSITIONS
JPS57128634A (en) * 1981-02-03 1982-08-10 Eisai Co Ltd Elastase-containing compound increasing absorption
EP0179583A1 (en) * 1984-10-04 1986-04-30 Merck & Co. Inc. A system for enhancing the water dissolution rate and solubility of poorly soluble drugs
JPS61280435A (en) * 1985-04-04 1986-12-11 Kanji Takada Lymph orienting preparation of cyclosporin

Also Published As

Publication number Publication date
FR2620336B1 (en) 1991-10-25
CH683672A5 (en) 1994-04-29
KR890004694A (en) 1989-05-09
KR0131084B1 (en) 1998-04-17
DK511188A (en) 1989-03-16
FI94837B (en) 1995-07-31
FI884192L (en) 1989-03-16
SE8803221L (en) 1989-03-16
NO179434C (en) 1996-10-09
SE503279C2 (en) 1996-05-13
GB2209671A (en) 1989-05-24
NL8802275A (en) 1989-04-03
PT88492B (en) 1993-03-31
DK511188D0 (en) 1988-09-14
AT395819B (en) 1993-03-25
GR880100602A (en) 1989-06-22
IT1224886B (en) 1990-10-24
GR1002243B (en) 1996-04-22
MY103769A (en) 1993-09-30
AU2217288A (en) 1989-04-27
JP3090666B2 (en) 2000-09-25
GB8821443D0 (en) 1988-10-12
PT88492A (en) 1988-10-01
FI884192A0 (en) 1988-09-13
FR2620336A1 (en) 1989-03-17
ES2012118A6 (en) 1990-03-01
JPH01151526A (en) 1989-06-14
LU87335A1 (en) 1989-04-06
HUT49494A (en) 1989-10-30
IL87746A0 (en) 1989-02-28
CA1338775C (en) 1996-12-10
DK175132B1 (en) 2004-06-14
IT8848349A0 (en) 1988-09-14
IE882772L (en) 1989-03-15
ATA224988A (en) 1992-08-15
IE61195B1 (en) 1994-10-19
AU628787B2 (en) 1992-09-24
NO179434B (en) 1996-07-01
NL195094C (en) 2003-12-17
SE8803221D0 (en) 1988-09-13
GB2209671B (en) 1991-11-13
FI94837C (en) 1995-11-10
IL87746A (en) 1992-07-15
NO884052D0 (en) 1988-09-13
HU205010B (en) 1992-03-30
NZ226163A (en) 1991-08-27
BE1001204A5 (en) 1989-08-16

Similar Documents

Publication Publication Date Title
NO883974L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE TETRAHYDRO-HYDROXYPYRANON DERIVATIVES.
NO884052L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC PREPARATION.
NO880262L (en) PROCEDURE FOR THE PREPARATION OF B AVERMECTINES.
NO883485D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PIPERIDINYL-ISOKINOLINE COMPOUNDS.
NO883122D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE ARYLAMIDE DERIVATIVES.
NO881643L (en) PROCEDURE FOR THE MANUFACTURE OF HIGH-STABLE SOFT MAGELATIN Capsules FOR THERAPEUTIC PURPOSES.
NO890155D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE INDOLPIPERIDIN COMPOUNDS.
NO880667L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE ARYLPIPERAZINYL-ALKYLENE-PHENYL-HETEROCYCLIC COMPOUNDS.
NO880910D0 (en) PROCEDURE FOR THE PREPARATION OF CHROMON DERIVATIVES.
NO884900L (en) PROCEDURE FOR THE PREPARATION OF GINKOLID DERIVATIVES.
NO170022C (en) PROCEDURE FOR THE PREPARATION OF SIALOCYLGYLEROLIPIDES.
NO882730L (en) PROCEDURE FOR THE PREPARATION OF AMINOCYCLOPENTYLETERS.
NO168247C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 5-METOXY-ALKYL-AMMONIUM-TETRAHYDROFURANES.
NO882491D0 (en) PROCEDURE FOR THE PREPARATION OF ANTI-VIRAL PHARMACEUTICAL PREPARATION.
NO882281D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PYRAZINAMIDES.
NO873571D0 (en) PROCEDURE FOR THE PREPARATION OF A THERAPEUTIC EFFECTIVE PREPARATION.
NO882655D0 (en) PROCEDURE FOR THE PREPARATION OF (E) -2- (P-FLUORPHENETHYL) -3-FLUORALLYLAMINE.
NO882282L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PYRAZINAMIDES.
NO883959D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PHENOLESTERS.
NO880834L (en) PROCEDURE FOR THE PREPARATION OF HETEROCYCLYL-2-PROPYN-1-AMINES.
NO880106D0 (en) PROCEDURE FOR THE PREPARATION OF THE LALKNITROGEN.
NO884100D0 (en) PROCEDURE FOR THE PREPARATION OF HALOGENTIAZOLD DERIVATIVES.
NO883398D0 (en) PROCEDURE FOR THE PREPARATION OF BENZOCSAZINE DERIVATIVES.
NO870151D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 2-PYRIMIDINAMIDES.
NO890375D0 (en) PROCEDURE FOR THE PREPARATION OF HEXANITROSTILBEN.

Legal Events

Date Code Title Description
MK1K Patent expired